$A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients$

A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients

Stereotactic ablative radiotherapy (SABR) is a promising option for non-operated early-stage non-small cell lung cancer (NSCLC) compared to conventional fractionated radiotherapy (CFRT). However, results from conclusive randomized controlled trials are not yet available. The aim of our study was to...

Full description

Bibliographic Details
Main Authors:	Tu Chih-Yen, Hsia Te-Chun, Fang Hsin-Yuan, Liang Ji-An, Yang Su-Tso, Li Chia-Chin, Chien Chun-Ru
Format:	Article
Language:	English
Published:	Sciendo 2017-12-01
Series:	Radiology and Oncology
Subjects:	stereotactic ablative radiotherapy conventional fractionated radiotherapy non-small cell lung cancer
Online Access:	https://doi.org/10.1515/raon-2017-0058

Similar Items

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
by: Jen-Fu Yang, et al.
Published: (2019-10-01)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
by: Bin Qiu, et al.
Published: (2020-08-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Evolution of Stereotactic Ablative Radiotherapy in Lung Cancer and Birmingham’s (UK) Experience
by: Sundus Yahya, et al.
Published: (2018-07-01)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
by: Robert Olson, et al.
Published: (2018-10-01)

Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report
by: Yeo SG
Published: (2017-07-01)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
by: Harish N. Vasudevan, et al.
Published: (2017-06-01)

Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case‐control study (PAULA‐1)
by: Alessandra Arcelli, et al.
Published: (2020-11-01)

Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
by: Raphael Jumeau, et al.
Published: (2020-06-01)

Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01)

Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis
by: Li M, et al.
Published: (2017-06-01)

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
by: Shao-Lun Lu, et al.
Published: (2016-08-01)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
by: Hanbo Chen, et al.
Published: (2018-08-01)

Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning Contours
by: Jordan Wong, et al.
Published: (2021-06-01)

Organizing pneumonia after stereotactic ablative radiotherapy of the lung
by: Murai Taro, et al.
Published: (2012-08-01)

Restricted bowel loop contouring: Improving efficiency in radiotherapy contouring for abdomino-pelvic Stereotactic Ablative Radiotherapy (SABR)
by: Eleanor Clarke, et al.
Published: (2020-09-01)

Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy
by: Megumi Uto, et al.
Published: (2021-07-01)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
by: Laura Burgess, et al.
Published: (2020-10-01)

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
by: Katrina Woodford, et al.
Published: (2017-10-01)

The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer
by: Shyama U. Tetar, et al.
Published: (2020-09-01)

Fractionated Stereotactic radiotherapy for POEMS syndrome: A case report
by: Juan Enrique Gutierrez Valencia, et al.
Published: (2019-01-01)

Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
by: Prabhakar Ramachandran, et al.
Published: (2017-01-01)

Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01)

Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma: Analysis of 29 cases from a single academic radiotherapy center
by: Liang-Cheng Chen, et al.
Published: (2021-01-01)

Precision Stereotactic Radiotherapy for Spinal Tumors: Mechanism, Efficacy, and Issues
by: Hongqing Zhuang, et al.
Published: (2020-05-01)

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer
by: Mix M, et al.
Published: (2019-12-01)

Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis
by: Conti Alfredo, et al.
Published: (2019-11-01)

Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial
by: Luke Nicholls, et al.
Published: (2020-11-01)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
by: Shih-Chang Wang, et al.
Published: (2020-05-01)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
by: Ting Martin Ma, et al.
Published: (2020-12-01)

Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review
by: Yining Gong, et al.
Published: (2019-10-01)

Influence of Radiotherapy Fractionation Schedule on the Tumor Vascular Microenvironment in Prostate and Lung Cancer Models
by: Karen Clément-Colmou, et al.
Published: (2020-01-01)

Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors
by: Atalar Banu, et al.
Published: (2020-06-01)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
by: Rupesh Kotecha, et al.
Published: (2021-09-01)

Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry
by: Sanne Nieuwenhuizen, et al.
Published: (2021-08-01)

Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
by: Carsten Herskind, et al.
Published: (2017-07-01)

Improving the therapeutic ratio of stereotactic radiosurgery and radiotherapy
by: Andisheh, Bahram
Published: (2012)

Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
by: Donna H. Murrell, et al.
Published: (2018-04-01)

Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis
by: Lei Wang, et al.
Published: (2020-01-01)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2019-09-01)